4.6 Review

Latest Advances of Virology Research Using CRISPR/Cas9-Based Gene-Editing Technology and Its Application to Vaccine Development

期刊

VIRUSES-BASEL
卷 13, 期 5, 页码 -

出版社

MDPI
DOI: 10.3390/v13050779

关键词

gene editing; CRISPR; Cas9; virus; gene function; vaccine

类别

资金

  1. National Natural Science Foundation of China [U1604232]
  2. Henan Thousand Talents Program-Leading Talents in Basic Research (2019-2020)
  3. Natural Science Foundation of Henan Province [212300410359]
  4. Key R&D and Promotion Project of Henan Province [212102110097]
  5. Fund for Distinguished Young Scholars from Henan Academy of Agricultural Sciences [2019JQ01]
  6. BBSRC Newton Fund Joint Centre Awards on UK-China Centre of Excellence for Research on Avian Diseases

向作者/读者索取更多资源

CRISPR/Cas9-based gene-editing techniques have been widely applied in biological sciences, particularly in modifying viral genomes, to reveal gene function, virus pathogenesis, and play a crucial role in vaccine development.
In recent years, the CRISPR/Cas9-based gene-editing techniques have been well developed and applied widely in several aspects of research in the biological sciences, in many species, including humans, animals, plants, and even in viruses. Modification of the viral genome is crucial for revealing gene function, virus pathogenesis, gene therapy, genetic engineering, and vaccine development. Herein, we have provided a brief review of the different technologies for the modification of the viral genomes. Particularly, we have focused on the recently developed CRISPR/Cas9-based gene-editing system, detailing its origin, functional principles, and touching on its latest achievements in virology research and applications in vaccine development, especially in large DNA viruses of humans and animals. Future prospects of CRISPR/Cas9-based gene-editing technology in virology research, including the potential shortcomings, are also discussed.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据